Compare ELAN & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELAN | BWXT |
|---|---|---|
| Founded | 1954 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.3B |
| IPO Year | 2018 | 2010 |
| Metric | ELAN | BWXT |
|---|---|---|
| Price | $26.29 | $117.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 18 |
| Target Price | $31.15 | ★ $199.19 |
| AVG Volume (30 Days) | ★ 4.7M | 1.2M |
| Earning Date | 11-06-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | N/A | ★ 16.61 |
| EPS | 0.26 | ★ 3.06 |
| Revenue | ★ $4,715,000,000.00 | $1,687,738,000.00 |
| Revenue This Year | $10.10 | $18.45 |
| Revenue Next Year | $4.97 | $8.91 |
| P/E Ratio | $101.08 | ★ $38.45 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $19.40 | $112.55 |
| 52 Week High | $27.98 | $241.82 |
| Indicator | ELAN | BWXT |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 36.47 |
| Support Level | $22.12 | $112.55 |
| Resistance Level | $27.66 | $129.98 |
| Average True Range (ATR) | 1.10 | 5.74 |
| MACD | 0.10 | -0.35 |
| Stochastic Oscillator | 74.64 | 20.69 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.